Recombinant Rat Prolactin receptor (Prlr)

What is Rat Prolactin Receptor and how does it compare to other species?

Rat Prolactin receptor (Prlr) is a membrane-anchored receptor that was first identified in 1975 as a specific, high-affinity receptor, with its cDNA isolated in the late 1980s . The receptor mediates the biological actions of prolactin, a neuroendocrine hormone primarily synthesized by the pituitary gland.

While human prolactin shares limited sequence identity with rat prolactin (approximately 63%), an important cross-species interaction exists: the human prolactin receptor can be activated by Rat Prolactin despite these sequence differences . This cross-reactivity makes rat models valuable for studying certain aspects of prolactin signaling relevant to human physiology. Rat Prolactin receptor belongs to the Somatotropin/Sclerostin/Serpin protein families, similar to its human counterpart .

What are the different forms of Rat Prolactin Receptor?

Rat Prolactin receptor exists in multiple isoforms, primarily categorized as short and long forms, which result from alternative splicing of the primary transcript. Both forms share identical extracellular domains but differ in their cytoplasmic domains.

The long form contains an extended intracellular domain crucial for activating the full spectrum of signaling pathways, particularly STAT5 signaling . The short form has a truncated intracellular domain with more limited signaling capabilities. Studies have shown that the expression pattern of these different forms varies significantly by tissue type and physiological state . For example, during lactation in rats, the expression levels of both short and long forms are significantly altered in specific brain regions compared to non-lactating states .

What signaling pathways are activated by Rat Prolactin Receptor?

Rat Prolactin receptor primarily mediates its biological functions through the activation of several signaling pathways:

• STAT5 Pathway: The primary and most well-characterized pathway, particularly important for metabolic regulation including hepatic insulin sensitivity .

• Extracellular Signal-Related Kinases (ERKs): Important for cell proliferation and differentiation responses to prolactin .

• Phosphatidylinositol 3-Kinase (PI3K) Pathway: Contributes to metabolic and growth responses .

These pathways work in concert to regulate various physiological processes. The STAT5 pathway appears particularly crucial, as research has demonstrated that STAT5 is required for PRLR-mediated regulation of insulin sensitivity . In the liver specifically, STAT5b is approximately 20-fold more abundant than STAT5a, making it the predominant mediator of prolactin signaling in hepatic tissue .

How is Rat Prolactin Receptor expressed in different tissues?

Rat Prolactin receptor exhibits widespread but tissue-specific expression patterns that can vary significantly based on physiological state. Expression has been documented in various tissues including:

• Brain Regions: Particularly in hypothalamic nuclei including supraoptic (SO), paraventricular (Pa), arcuate (Arc) and ventromedial hypothalamic (VMH) nuclei. Notably, expression levels change dramatically between different physiological states .

• Choroid Plexus (ChP): Shows significant expression with marked upregulation during lactation .

• Thymus: Prolactin receptor has been detected in the cytoplasm of lymphocytes in rat thymus, suggesting important immunomodulatory functions .

• Liver: Expresses Prolactin receptor with importance for metabolic regulation, particularly insulin sensitivity .

Table 1: Relative Expression of Prolactin Receptor mRNA Forms in Rat Brain Regions

*Indicates statistically significant difference (P<0.05) compared to dioestrous state .

How does the expression of Rat Prolactin Receptor change during lactation?

Lactation induces profound changes in Prolactin receptor expression in rats, particularly in the brain. Research using reverse transcription-PCR and Southern hybridization has demonstrated:

• Short Form Expression: Significantly increased in the choroid plexus of lactating rats compared to dioestrous rats. Moreover, short form mRNA becomes detectable in the supraoptic nucleus, paraventricular nucleus, and ventromedial hypothalamus during lactation despite being undetectable during dioestrus .

• Long Form Expression: Significantly amplified in multiple brain regions including the choroid plexus, supraoptic nucleus, paraventricular nucleus, and ventromedial hypothalamus in lactating compared to dioestrous rats .

• Cortical Expression: Long form mRNA appears to be induced in the parietal cortex during lactation .

These changes in expression likely underlie many of the physiological and behavioral adaptations observed during lactation. The increased expression of Prolactin receptor in specific brain regions during lactation is consistent with prolactin's diverse effects on the brain and may help explain the profound physiological changes in lactating mothers .

What methods are recommended for detecting Rat Prolactin Receptor in tissue samples?

Several validated methods can be employed for detecting Rat Prolactin receptor in tissue samples:

• Immunohistochemistry (IHC): For detecting Prolactin receptor in tissue sections, researchers have successfully used antibodies such as Goat Anti-Rat Prolactin R Antigen Affinity-purified Polyclonal Antibody. Protocol specifics include:

  • Concentration: 15 μg/mL

  • Incubation: Overnight at 4°C

  • Visualization: Anti-Goat HRP-DAB staining systems

  • Counterstaining: Hematoxylin

  This approach has successfully localized Prolactin receptor to the cytoplasm of lymphocytes in rat thymus .

• RT-PCR and Southern Hybridization: Effective for quantifying mRNA expression of both short and long forms of the receptor. This approach has been combined with microdissection techniques to provide precise neuroanatomical localization in brain tissue .

• Primer Sequences for Specific Detection: For detecting the mouse long-form PRLR, the following primers have been validated:

  • Sense primer: 5′-TGAGGACGAGCGGCTAATG-3′

  • Antisense primer: 5′-GGTGTGTGGGTTTAACACCTTGA-3′

How can recombinant Rat Prolactin Receptor be used in functional assays?

Recombinant Rat Prolactin receptor can be utilized in various functional assays to study prolactin signaling and receptor activity:

• Cell Proliferation Assays: The Nb2-11 rat lymphoma cell line has been established as a responsive model system. Human Prolactin stimulates proliferation in these cells in a dose-dependent manner, and this proliferation can be neutralized by Anti-Rat Prolactin R antibodies. Specifically, 25 μg/mL of antibody (such as AF1112) has been shown to neutralize prolactin-induced activity by >60% .

• Receptor Expression Systems: Adenoviral vectors can be used to overexpress or knock down PRLR expression. For example:

  • Overexpression: Adenoviral vectors containing mouse long-form PRLR cDNA have been used to study effects on insulin sensitivity .

  • Knockdown: Adenoviral vectors expressing shRNA specific for PRLR (target sequence: 5′-GCCACCTACCATAACTGATGT-3′) have been utilized to reduce receptor expression .

• Signaling Pathway Analysis: Downstream effects of receptor activation can be studied using phosphorylation-specific antibodies for STAT5, ERK, and other signaling molecules .

What experimental models are most suitable for studying Rat Prolactin Receptor function?

Several experimental models have proven valuable for studying Rat Prolactin receptor function:

• Cell Culture Models:

  • Nb2-11 rat lymphoma cell line: Highly responsive to prolactin, making it useful for proliferation assays and studying receptor neutralization .

  • Hepatocytes: Valuable for studying metabolic effects, particularly insulin sensitivity regulation .

• Animal Models:

  • Lactating vs. Non-lactating Rats: Provide natural physiological contrasts in receptor expression and function .

  • db/db Mice: A genetic model for insulin resistance that shows decreased PRLR protein levels in the liver, useful for studying metabolic functions .

  • Adenovirus-Modified Mice: Overexpression or knockdown of PRLR in specific tissues can be achieved through adenoviral delivery, allowing targeted functional studies .

• Tissue-Specific Studies:

  • Brain Micropunch Technique: Enables the study of receptor expression in specific brain nuclei with relatively precise neuroanatomical localization .

  • Perfusion-Fixed Frozen Sections: Allow for immunohistochemical detection of receptor expression in specific cell types .

How do PRLR genetic variants affect receptor function?

Research on PRLR variants has revealed diverse effects on receptor function, providing insights into structure-function relationships:

• Activating Variants:

  • Ile146Leu: Demonstrates constitutive activity and is overrepresented in benign breast disease .

  • Asn492Ile: A rare activating variant associated with increased incidence of prolactinoma .

• Inactivating Variants:

  • His188Arg: An inactivating germline heterozygous variant reported in a kindred with hyperprolactinaemia .

  • Pro269Leu/Arg171Stop: An inactivating compound heterozygous variant identified in an individual with hyperprolactinaemia and agalactia .

These findings demonstrate that Prolactin receptor variants can have opposing effects (activation or inactivation), leading to different clinical manifestations. Large-scale sequencing projects (ExAC and GnomAD) have identified >300 previously uncharacterized non-synonymous, germline PRLR variants, suggesting that many more functional variants remain to be characterized .

What is the relationship between PRLR and insulin sensitivity?

Recent research has uncovered an important role for Prolactin receptor in regulating insulin sensitivity, particularly in the liver:

• Metabolic Impact:

  • Whole-body and hepatic insulin sensitivity are improved or impaired in mice with overexpression or knockdown of PRLR, respectively .

  • PRLR expression is decreased in insulin-resistant conditions, such as in db/db mice compared to wild-type mice .

  • Restoration of PRLR expression in db/db mice via adenoviral injection significantly decreases fed and fasting blood glucose levels and improves glucose tolerance and clearance .

• Signaling Mechanisms:

  • STAT5 is required for the regulation of insulin sensitivity by PRLR .

  • In the liver, STAT5b is 20-fold more abundant than STAT5a, making it the predominant mediator of this effect .

• Clinical Implications:

  • These findings suggest that targeting PRLR signaling could potentially represent a novel therapeutic approach for insulin resistance and related metabolic disorders .

What are the technical challenges in working with recombinant Rat Prolactin Receptor?

Researchers working with recombinant Rat Prolactin receptor face several technical challenges:

• Isoform Specificity:

  • The existence of multiple isoforms (long and short forms) requires careful experimental design to target specific forms. Researchers must select appropriate primers, antibodies, or expression constructs that can distinguish between these forms .

• Cross-Species Reactivity:

  • While human prolactin can activate rat receptors despite sequence differences, researchers must carefully consider species-specific effects when designing experiments and interpreting results .

• Tissue-Specific Expression:

  • Expression levels vary dramatically across tissues and physiological states, necessitating careful selection of experimental models and control conditions .

• Signaling Complexity:

  • Multiple downstream pathways can be activated by PRLR, requiring comprehensive analysis of signaling outcomes rather than focusing on a single pathway .

What emerging areas of Rat Prolactin Receptor research show promise?

Several promising research directions for Rat Prolactin receptor are emerging:

• Metabolic Regulation:

  • Further characterization of PRLR's role in insulin sensitivity and glucose homeostasis could lead to novel therapeutic approaches for metabolic disorders .

• Variant Characterization:

  • Functional characterization of numerous uncharacterized PRLR variants identified in large-scale sequencing projects may reveal new insights into receptor function and disease associations .

• Neuroendocrine Functions:

  • The dramatic changes in receptor expression in specific brain regions during different physiological states suggest important neuroendocrine functions that warrant further investigation .

• Immunomodulatory Roles:

  • Detection of PRLR in lymphocytes suggests immunomodulatory functions that could be relevant to understanding immune system regulation .

How can contradictory data on Rat Prolactin Receptor function be reconciled?

Researchers encountering contradictory data regarding Rat Prolactin receptor function should consider:

• Isoform-Specific Effects:

  • Different isoforms (long vs. short) may have opposing or complementary functions. Experimental approaches that fail to distinguish between isoforms might yield seemingly contradictory results .

• Tissue-Specific Contexts:

  • PRLR function can vary dramatically across different tissues. For example, changes in receptor expression during lactation are not uniform across brain regions, with some areas showing significant increases while others show no change .

• Physiological State Influence:

  • The functional significance of PRLR can change dramatically based on physiological state (e.g., dioestrus vs. lactation), potentially leading to different experimental outcomes in otherwise similar models .

• Methodological Considerations:

  • Different detection methods (protein vs. mRNA, different antibodies) may yield different results. Researchers should employ multiple complementary approaches to confirm findings .